Massachusetts Financial Services’s Oruka Therapeutics ORKA Stock Holding History

Massachusetts Financial Services’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.7M	Buy	+364,102	New	+$24.3M	0.01%	570

Other funds holding ORKA

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

SAM

Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Massachusetts Financial Services's ORKA Position: Q2 2026 in Review

Massachusetts Financial Services opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 364,102 shares worth $34.7M. The stake represents 0.01% of the portfolio and ranks #570 among its holdings.

49 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

Massachusetts Financial Services held 364,102 shares of Oruka Therapeutics worth $34.7M as of Q2 2026.
Oruka Therapeutics was a new Massachusetts Financial Services position in Q2 2026.
Oruka Therapeutics made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #570 holding.
49 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.